載入...
Targeting ACE2–RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay
[Image: see text] The COVID-19 pandemic, caused by SARS-CoV-2, is a pressing public health emergency garnering a rapid response from scientists across the globe. Host cell invasion is initiated through direct binding of the viral spike protein to the host receptor angiotensin-converting enzyme 2 (AC...
Na minha lista:
| 發表在: | ACS Pharmacol Transl Sci |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American
Chemical Society
2020
|
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7688046/ https://ncbi.nlm.nih.gov/pubmed/33330843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.0c00161 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|